{"meta":{"query_hash":"787a4d9a159c","filters":{"venue":"Hormones and Cancer"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/787a4d9a159c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hormones+and+Cancer"},"results":[{"id":"W1109785384","doi":"10.1007/s12672-015-0233-2","title":"Symptomatic Control of Neuroendocrine Tumours with Everolimus","year":2015,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Everolimus; Medicine; Neuroendocrine tumors; Carcinoid syndrome; Octreotide; Internal medicine; Gastroenterology; Cohort; Surgery","score_opus":0.02052314898579008,"score_gpt":0.30172888013108096,"score_spread":0.2812057311452909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1109785384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90881383,0.07053583,0.006743725,0.0022316787,0.000496742,0.00005805113,0.00013636833,0.0002694956,0.010714341],"genre_scores_gemma":[0.9912237,0.005399992,0.0010589462,0.00028445176,0.00023102574,0.000015218237,0.00012040036,0.000022827706,0.0016434209],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99992895,0.000017137658,0.0000075803737,0.000008675108,0.00002052373,0.000017119934],"domain_scores_gemma":[0.9999018,0.000038526156,0.000021978669,0.000008822396,0.0000073469223,0.000021559812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018884373,0.00020285402,0.00041159728,0.00019106823,0.00014451332,0.00026173724,0.00022747174,0.00019825506,0.00065515854],"category_scores_gemma":[0.0002936969,0.00004983182,0.000323381,0.00014987883,0.00018855621,0.00032309318,0.00015165715,0.00065998593,0.00014510528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01224298,0.0010129577,0.008666373,0.0009853637,0.0005195908,0.0037541273,0.00028587785,0.0019819173,0.2585381,0.0037864626,0.004185512,0.70404065],"study_design_scores_gemma":[0.0065318965,0.049631562,0.30073118,0.00061001943,0.0012519264,0.05071119,0.00064740586,0.015551003,0.3741166,0.010529057,0.18947697,0.00021120365],"about_ca_topic_score_codex":0.00020579694,"about_ca_topic_score_gemma":0.00063739595,"teacher_disagreement_score":0.00065515854,"about_ca_system_score_codex":0.00016430981,"about_ca_system_score_gemma":0.00014846738,"threshold_uncertainty_score":0.0021916628},"labels":[],"label_agreement":null},{"id":"W1968681830","doi":"10.1007/s12672-014-0209-7","title":"The Relationship Between Bilateral Oophorectomy and Plasma Hormone Levels in Postmenopausal Women","year":2014,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Cancer Care Ontario","keywords":"Oophorectomy; Estrone; Estrone sulfate; Dehydroepiandrosterone sulfate; Medicine; Hysterectomy; Testosterone (patch); Menopause; Sex hormone-binding globulin; Prolactin; Estrogen; Internal medicine; Endocrinology; Hormone; Surgical Menopause; Androgen; Surgery","score_opus":0.03328219526002421,"score_gpt":0.29818345385532374,"score_spread":0.26490125859529956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968681830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635714,0.0023828542,0.000055094366,0.00012980266,0.000019673409,0.000002937807,0.0001822434,0.0000041147864,0.00086609833],"genre_scores_gemma":[0.9991553,0.00045544718,0.000038249604,0.000034912726,0.000019673103,0.0000023460168,0.00007271892,0.0000011231564,0.0002202467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998859,0.000035249162,0.000011440434,0.000016904221,0.000021355634,0.000029177752],"domain_scores_gemma":[0.998973,0.00046921623,0.00028113584,0.000058585727,0.000047321257,0.00017075674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025495025,0.0001229811,0.00023528966,0.00036805435,0.00022278777,0.00034722363,0.00013707242,0.0003905363,0.0014026593],"category_scores_gemma":[0.0022795973,0.00022546385,0.00027950178,0.00073724304,0.00024853108,0.00025754952,0.00018760968,0.000541083,0.00011572099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012436635,0.0000448748,0.9940665,0.000014518436,0.0000863831,0.00014039746,0.00007037056,0.000045683868,0.0008497552,0.000023778905,0.00006241756,0.0033515152],"study_design_scores_gemma":[0.000010923195,0.00011044405,0.999297,0.0000027145807,0.000039859173,0.0001727251,0.00007591592,0.0000584959,0.00005436747,0.000027383814,0.0001480201,0.0000020320297],"about_ca_topic_score_codex":0.0064990115,"about_ca_topic_score_gemma":0.007931166,"teacher_disagreement_score":0.0064990115,"about_ca_system_score_codex":0.00022547522,"about_ca_system_score_gemma":0.00033917293,"threshold_uncertainty_score":0.012922406},"labels":[],"label_agreement":null},{"id":"W1969670583","doi":"10.1007/s12672-010-0049-z","title":"Estrogen Receptor Alpha Phosphorylated at Tyrosine 537 is Associated with Poor Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen","year":2010,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Manitoba","funders":"Canadian Institutes of Health Research; Strong; CancerCare Manitoba Foundation","keywords":"Breast cancer; Tissue microarray; Estrogen receptor; Immunohistochemistry; Tamoxifen; Oncology; Internal medicine; Medicine; Estrogen receptor alpha; Cancer; Univariate analysis; Cancer research; Endocrinology; Pathology; Multivariate analysis","score_opus":0.006865548082641771,"score_gpt":0.2604841833744748,"score_spread":0.25361863529183304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969670583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901795,0.00042929107,0.000029069166,0.00007578543,0.000013015185,0.000002180701,0.000068122215,0.0000026250693,0.00036205532],"genre_scores_gemma":[0.9994223,0.00018609106,0.000020372221,0.000042061933,0.000025208261,0.0000033141557,0.00009902931,0.000001378967,0.00020030775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998611,0.00003886108,0.000016844004,0.00002058848,0.000026513442,0.000036124402],"domain_scores_gemma":[0.9991009,0.00022495509,0.00041671758,0.000031495776,0.00006069488,0.0001651473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020622968,0.00020500219,0.0004655185,0.00053217093,0.00039000204,0.0005191853,0.0002206678,0.00056239974,0.0012348432],"category_scores_gemma":[0.0013753722,0.00026092323,0.0003419611,0.0007987109,0.0002657796,0.00025069487,0.00020241602,0.0005407639,0.00019041968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017363599,0.00007612978,0.9928619,0.000013240618,0.000099961784,0.00036526524,0.000053132808,0.00004194874,0.0026480756,0.000017186087,0.000106502564,0.0019803063],"study_design_scores_gemma":[0.000026728534,0.00016932326,0.9985483,0.0000036603305,0.00008544106,0.00063562416,0.00007203166,0.000117351345,0.00018671122,0.00002607478,0.00012572792,0.0000030426897],"about_ca_topic_score_codex":0.0016296454,"about_ca_topic_score_gemma":0.0021843028,"teacher_disagreement_score":0.0016296454,"about_ca_system_score_codex":0.000197045,"about_ca_system_score_gemma":0.00019458552,"threshold_uncertainty_score":0.0041309},"labels":[],"label_agreement":null},{"id":"W1982550511","doi":"10.1007/s12672-015-0218-1","title":"Androgen Pathway Manipulation and Survival in Patients with Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Cancer registry; Cancer; Proportional hazards model; Oncology; Retrospective cohort study; Epidemiology; Cohort; Population; Prostate cancer; Hazard ratio; Cohort study; Gynecology","score_opus":0.016868394556311034,"score_gpt":0.2968106626372282,"score_spread":0.27994226808091716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982550511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97132593,0.024522956,0.000093646064,0.0008212344,0.0000976609,0.000009635182,0.00046037673,0.000016162105,0.0026524223],"genre_scores_gemma":[0.99588627,0.0027582245,0.000051917443,0.00023814135,0.00005997047,0.000004181093,0.0003027964,0.0000019993147,0.0006964865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998795,0.000031211828,0.0000100559155,0.000017219969,0.000027012333,0.000035012574],"domain_scores_gemma":[0.9996952,0.000091695525,0.00011070945,0.000014040713,0.000022190616,0.00006626619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019859544,0.00011834861,0.000312846,0.00016938346,0.00018501957,0.00043879074,0.00014209475,0.00026532792,0.0014396206],"category_scores_gemma":[0.00085445587,0.000072351,0.00041800836,0.00033159493,0.00015504134,0.00025274395,0.00016048353,0.0005150818,0.00013167296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010737104,0.00055679993,0.8672139,0.00020867914,0.00075992465,0.000413762,0.000098859244,0.00049013563,0.005152879,0.00026883854,0.0018832122,0.112215996],"study_design_scores_gemma":[0.0002765851,0.0032575345,0.9890542,0.00005425257,0.0006640761,0.0007424523,0.00021241086,0.00030811952,0.00095248973,0.00044281752,0.0040226122,0.000012329529],"about_ca_topic_score_codex":0.0014352062,"about_ca_topic_score_gemma":0.0039140224,"teacher_disagreement_score":0.0014396206,"about_ca_system_score_codex":0.00035845116,"about_ca_system_score_gemma":0.00031649845,"threshold_uncertainty_score":0.0048160553},"labels":[],"label_agreement":null},{"id":"W2007488022","doi":"10.1007/s12672-010-0013-y","title":"Circulating Insulin-like Growth Factor (IGF)-I and IGF Binding Protein (IGFBP)-3 Levels and Postmenopausal Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort","year":2010,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Prevention, National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Hazard ratio; Breast cancer; Internal medicine; Oncology; Proportional hazards model; Prospective cohort study; Insulin-like growth factor; Risk factor; Cancer; Prostate cancer; Gynecology; Endocrinology; Confidence interval; Growth factor","score_opus":0.015272674043149494,"score_gpt":0.2687764677882709,"score_spread":0.25350379374512144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007488022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778914,0.00037857535,0.00007197271,0.00013242656,0.000025292278,0.000014152371,0.0010735864,0.000011787222,0.0005030311],"genre_scores_gemma":[0.99759847,0.0002213868,0.000080557395,0.00009842416,0.0000467494,0.000026184502,0.0013202702,0.0000050727335,0.0006029852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997458,0.00008050644,0.000014537607,0.00006414353,0.000033467742,0.00006151663],"domain_scores_gemma":[0.9992649,0.00013962454,0.00018030129,0.00011167203,0.00003595408,0.0002674686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007687408,0.00069775607,0.000991384,0.00030553588,0.00059824786,0.0011790168,0.0004457057,0.0006915201,0.0019764954],"category_scores_gemma":[0.0012542539,0.00061686663,0.0012298807,0.00079919206,0.0004890421,0.00046181466,0.00058971276,0.0012581869,0.00020353639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09254881,0.00082624704,0.8889376,0.00010338076,0.0020946367,0.0006224392,0.0001902996,0.00062281295,0.005190341,0.0002944895,0.0025696892,0.005999261],"study_design_scores_gemma":[0.007789251,0.0019722881,0.98369825,0.000024039382,0.0028656377,0.00047286926,0.00017614572,0.0012148191,0.00043433247,0.00028592008,0.0010343938,0.00003200637],"about_ca_topic_score_codex":0.013694527,"about_ca_topic_score_gemma":0.016562596,"teacher_disagreement_score":0.013694527,"about_ca_system_score_codex":0.00052539026,"about_ca_system_score_gemma":0.0008290143,"threshold_uncertainty_score":0.027229607},"labels":[],"label_agreement":null},{"id":"W2018899393","doi":"10.1007/s12672-011-0096-0","title":"Beyond Castration—Defining Future Directions in the Hormonal Treatment of Prostate Cancer","year":2011,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Cancer; Testosterone (patch); Abiraterone acetate; Androgen; Castration; Enzalutamide; Medicine; Intracrine; Abiraterone; Internal medicine; Prostate; Oncology; Androgen deprivation therapy; Cancer research; Hormone; Androgen receptor","score_opus":0.06339424091530371,"score_gpt":0.3743805644422678,"score_spread":0.3109863235269641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018899393","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027555758,0.9993594,0.000030200852,0.00026780408,0.00009499129,9.734229e-7,0.0000049629957,0.0000017523399,0.00021226764],"genre_scores_gemma":[0.0002442731,0.9990609,0.00008307787,0.00026588366,0.00017626055,0.0000015832866,0.000009484493,6.346093e-7,0.00015788084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996377,0.00008836666,0.00006154467,0.000050475912,0.0001242357,0.000037674316],"domain_scores_gemma":[0.9991684,0.0004939413,0.00010483003,0.00001790672,0.00015777755,0.00005719864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014739395,0.00082957064,0.0022883997,0.002332771,0.00038827775,0.0018462621,0.0012830672,0.0013452523,0.003428317],"category_scores_gemma":[0.001485407,0.00039357238,0.0005903038,0.0038099866,0.0011641413,0.0027171064,0.0009284583,0.0032374107,0.0015433333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018010917,0.000080286285,0.0002520303,0.017833227,0.00012136899,0.0002492713,0.00007659459,0.0004922922,0.0010579497,0.005856617,0.040066052,0.9337342],"study_design_scores_gemma":[0.000049752893,0.0001100862,0.0009784343,0.005960119,0.00016157984,0.0008837104,0.00014546813,0.00014450066,0.00018007545,0.004103528,0.9872537,0.000028915432],"about_ca_topic_score_codex":0.0034563541,"about_ca_topic_score_gemma":0.009116763,"teacher_disagreement_score":0.0034563541,"about_ca_system_score_codex":0.0012007619,"about_ca_system_score_gemma":0.0022285422,"threshold_uncertainty_score":0.011468828},"labels":[],"label_agreement":null},{"id":"W2052554512","doi":"10.1007/s12672-010-0008-8","title":"Quantitative Immunohistochemical Analysis and Prognostic Significance of TRPS-1, a New GATA Transcription Factor Family Member, in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi Pasteur; University of Texas MD Anderson Cancer Center; National Cancer Institute; Sanofi","keywords":"Immunohistochemistry; Breast cancer; Medicine; Oncology; Internal medicine; Progesterone receptor; Prostate cancer; Estrogen receptor; Cancer; Cancer research; Endocrinology","score_opus":0.034546940706006266,"score_gpt":0.31292516034254675,"score_spread":0.27837821963654047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052554512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980033,0.00053113047,0.0006423884,0.000024819978,0.0000055154687,0.000008125443,0.00005023369,0.000009520465,0.00072499266],"genre_scores_gemma":[0.99943453,0.000086988846,0.00027634006,0.000004131497,0.0000070932274,0.0000043411083,0.00004254991,0.0000019054892,0.00014203985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997799,0.000062403305,0.000018234761,0.000043551776,0.000044817167,0.00005117158],"domain_scores_gemma":[0.9996259,0.00016370573,0.00006656581,0.000038490372,0.000055536722,0.00004973463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006421501,0.00015640384,0.00013521526,0.0009935597,0.00022958833,0.00029725506,0.0002696732,0.00029739653,0.0012900309],"category_scores_gemma":[0.0008121081,0.000154792,0.00013819596,0.00040636462,0.0005048169,0.00031592778,0.00017280669,0.00021494982,0.00013566727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028128165,0.00017554245,0.63643277,0.00013154131,0.00011851104,0.0065061064,0.00054614834,0.00045839368,0.33430225,0.00076556526,0.00032115472,0.01742917],"study_design_scores_gemma":[0.000089687936,0.00080584845,0.9041009,0.000015179026,0.00030651383,0.0276158,0.00094038324,0.00424802,0.05711671,0.000959125,0.0037742516,0.000027566992],"about_ca_topic_score_codex":0.0004635261,"about_ca_topic_score_gemma":0.00041543003,"teacher_disagreement_score":0.0012900309,"about_ca_system_score_codex":0.00020762737,"about_ca_system_score_gemma":0.000091482834,"threshold_uncertainty_score":0.004315555},"labels":[],"label_agreement":null},{"id":"W2061481386","doi":"10.1007/s12672-012-0105-y","title":"Differential Role of Estrogen Receptor Beta in Early Versus Metastatic Non-small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Lung cancer; Oncology; Estrogen receptor; Univariate analysis; Cohort; Immunohistochemistry; Multivariate analysis; Cancer; Stage (stratigraphy); Estrogen; Breast cancer; Pathology; Biology","score_opus":0.013763272116483975,"score_gpt":0.30095409300934683,"score_spread":0.28719082089286285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061481386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9470609,0.045858137,0.00035886787,0.00056634156,0.000061821964,0.000011154266,0.0002821082,0.000023993036,0.0057766284],"genre_scores_gemma":[0.9931564,0.00497533,0.00012206004,0.00008333548,0.000038069516,0.000004287769,0.00013128578,0.0000063685134,0.0014827311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986327,0.000039116683,0.00000852708,0.000014431674,0.000032781198,0.000041782772],"domain_scores_gemma":[0.9997625,0.00010064684,0.000043213913,0.000017736866,0.000034854005,0.000041062296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034885245,0.00015991696,0.00039836497,0.0005098568,0.00012457269,0.0006260214,0.00019709874,0.0002234038,0.0016713302],"category_scores_gemma":[0.0006545609,0.00013111703,0.00022724738,0.00026092128,0.00020798044,0.00028912586,0.00016625867,0.00027782825,0.00023253445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011029302,0.00033430374,0.33459744,0.00042576905,0.00032496644,0.003770209,0.0003488217,0.00073373923,0.4752054,0.0022409635,0.0014606704,0.16952838],"study_design_scores_gemma":[0.00019604347,0.0019076547,0.89767426,0.00008455803,0.0003834778,0.0070169023,0.0006428904,0.00064240413,0.07867955,0.0012634876,0.011487456,0.000021262356],"about_ca_topic_score_codex":0.0007686587,"about_ca_topic_score_gemma":0.0010547613,"teacher_disagreement_score":0.0016713302,"about_ca_system_score_codex":0.00035799202,"about_ca_system_score_gemma":0.00020676265,"threshold_uncertainty_score":0.0055912137},"labels":[],"label_agreement":null},{"id":"W2086359001","doi":"10.1007/s12672-013-0165-7","title":"Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland","year":2013,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Prolactin receptor; Prolactin; Breast cancer; Estrogen receptor; Internal medicine; Carcinogenesis; Endocrinology; Population; Tissue microarray; Medicine; Estrogen receptor alpha; Receptor expression; Receptor; Biology; Cancer; Cancer research; Oncology; Hormone","score_opus":0.0033355770091963903,"score_gpt":0.20980862622993995,"score_spread":0.20647304922074355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086359001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996408,0.0001168306,0.000069006615,0.0000066853054,0.0000020195587,0.0000064416663,0.000055059547,0.000001041622,0.00010208014],"genre_scores_gemma":[0.9995497,0.00008480421,0.000057269546,0.000011713694,0.0000033463716,0.000008124245,0.00011966008,0.0000017817399,0.00016360865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995499,0.00008364096,0.000065418426,0.00015899111,0.00006556545,0.00007644046],"domain_scores_gemma":[0.99973303,0.000043053038,0.00008170202,0.000036394005,0.00003832271,0.00006735691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035951106,0.00036634554,0.00056084787,0.0009714665,0.00061685394,0.00074437115,0.00038651063,0.00037513432,0.0010397027],"category_scores_gemma":[0.00060343527,0.00071601983,0.0007027354,0.0011294428,0.00044466852,0.00032940856,0.0005348532,0.0004094129,0.00018215788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005095724,0.00011027624,0.99550325,0.000019994544,0.00018280842,0.0004434979,0.00035629212,0.000021582342,0.0017382468,0.000026604239,0.00004433911,0.0010435135],"study_design_scores_gemma":[0.000025796095,0.00011707295,0.99861646,0.000002360063,0.000092710594,0.000517147,0.00032219835,0.00005258615,0.00009767856,0.000008071657,0.00014460042,0.0000032150035],"about_ca_topic_score_codex":0.010872887,"about_ca_topic_score_gemma":0.01004038,"teacher_disagreement_score":0.010872887,"about_ca_system_score_codex":0.0004353794,"about_ca_system_score_gemma":0.0003667575,"threshold_uncertainty_score":0.0216192},"labels":[],"label_agreement":null},{"id":"W2095200029","doi":"10.1007/s12672-013-0149-7","title":"Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada","year":2013,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Winnipeg Foundation; Manitoba Medical Service Foundation; Manitoba Health Research Council","keywords":"Antiestrogen; Medicine; Lung cancer; Oncology; Proportional hazards model; Cancer; Internal medicine; Cancer registry; Population; Hazard ratio; Incidence (geometry); Retrospective cohort study; Breast cancer; Estrogen receptor; Environmental health","score_opus":0.004686969256018233,"score_gpt":0.19148655909193726,"score_spread":0.18679958983591904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095200029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473597,0.0025607578,0.00009464531,0.0011122794,0.000046584923,0.000048370624,0.0073949383,0.000020001236,0.0039864196],"genre_scores_gemma":[0.99223644,0.0020478023,0.00012246291,0.00025914275,0.000017488172,0.000021416989,0.0017080781,0.000008755113,0.0035783174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996264,0.00004018569,0.000032447293,0.000049295733,0.00010812258,0.00014355272],"domain_scores_gemma":[0.99874735,0.00006819742,0.0001729892,0.000026932901,0.0006058797,0.0003786526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031045685,0.00031179134,0.00039461436,0.0016140714,0.00209766,0.00093377184,0.0011382229,0.00051253726,0.002388762],"category_scores_gemma":[0.0010960756,0.000390034,0.0005494061,0.0049521383,0.000647112,0.00031891005,0.0005756637,0.0006996028,0.00030484455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011677426,0.000033334185,0.99600214,0.00002546903,0.000050492254,0.00014170536,0.00040013785,0.00008606765,0.0002448708,0.00006927467,0.0008576376,0.0019721768],"study_design_scores_gemma":[0.000019656358,0.000033699383,0.9967229,0.00003524912,0.000054318414,0.00010297556,0.0014773776,0.00017652687,0.000076355514,0.000024974783,0.0012654082,0.000010549303],"about_ca_topic_score_codex":0.99443036,"about_ca_topic_score_gemma":0.9971859,"teacher_disagreement_score":0.015959632,"about_ca_system_score_codex":0.015959632,"about_ca_system_score_gemma":0.022829024,"threshold_uncertainty_score":0.11579579},"labels":[],"label_agreement":null},{"id":"W2564769671","doi":"10.1007/s12672-016-0280-3","title":"Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases","year":2017,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Focal adhesion; Proto-oncogene tyrosine-protein kinase Src; Integrin; Cell biology; Cell migration; PTK2; Cancer research; Actin cytoskeleton; Tyrosine kinase; PI3K/AKT/mTOR pathway; Biology; Kinase; Extracellular matrix; Signal transduction; Cytoskeleton; Cell; Protein kinase A; Biochemistry","score_opus":0.016558099744646948,"score_gpt":0.3062827640482007,"score_spread":0.28972466430355376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564769671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268384,0.006831795,0.0011390989,0.00065133045,0.00012549336,0.00002072196,0.00046078677,0.0001423778,0.0079446845],"genre_scores_gemma":[0.9931076,0.0013782625,0.00029615648,0.00009041639,0.000018294411,0.000012436149,0.00020307148,0.00001983697,0.0048738574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981767,0.000020423124,0.0000075300904,0.000025143067,0.000029295481,0.00009992446],"domain_scores_gemma":[0.99992895,0.000007944329,0.000018450415,0.0000074067943,0.000013311522,0.000023837343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009999933,0.0002317624,0.00014070292,0.00023132487,0.00044597025,0.000615593,0.00022267012,0.00022590905,0.0021067727],"category_scores_gemma":[0.00019301982,0.00019536522,0.0003606435,0.00018432141,0.0002777933,0.0002829657,0.00027714862,0.00036951387,0.0005551496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010773742,0.00004841747,0.0032063476,0.00006828023,0.00003439415,0.00019584464,0.00012895622,0.00015078006,0.98633283,0.0006724575,0.0007521502,0.0073320954],"study_design_scores_gemma":[0.00031547283,0.0007350173,0.22986582,0.00003578758,0.00025409076,0.00085194246,0.001334969,0.0042017982,0.7295058,0.0009384603,0.031914435,0.00004631451],"about_ca_topic_score_codex":0.016533038,"about_ca_topic_score_gemma":0.024341868,"teacher_disagreement_score":0.016533038,"about_ca_system_score_codex":0.0014499519,"about_ca_system_score_gemma":0.00066374254,"threshold_uncertainty_score":0.03287363},"labels":[],"label_agreement":null},{"id":"W2609422755","doi":"10.1007/s12672-017-0292-7","title":"Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps","year":2017,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage College","funders":"AMVETS","keywords":"Vemurafenib; Melanoma; Cancer research; Pharmacology; Efflux; Gene knockdown; Drug resistance; ATP-binding cassette transporter; Biology; Medicine; Cell culture; Transporter","score_opus":0.008976481457474645,"score_gpt":0.2622209727446267,"score_spread":0.25324449128715204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609422755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051476,0.004095999,0.0013885828,0.0004664943,0.00010517118,0.000031596614,0.0004572451,0.00021476681,0.0027253197],"genre_scores_gemma":[0.99323094,0.0015384794,0.00068069017,0.00009460109,0.00001382271,0.000015624826,0.00035512424,0.00002526814,0.004045425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999294,0.000009362891,0.000006417071,0.000014312065,0.000017601791,0.000022864577],"domain_scores_gemma":[0.99996746,0.0000062800273,0.000008661422,0.000005843355,0.0000045443735,0.0000071994273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006395093,0.00020095185,0.00020249422,0.00016572086,0.0001390484,0.00035899732,0.00011227906,0.00017013564,0.0018265429],"category_scores_gemma":[0.0000735557,0.00013499366,0.00017025201,0.00013605112,0.00019482819,0.00019043022,0.000104832085,0.0004531518,0.00030348107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007340988,0.000020464448,0.00015832871,0.000020512533,0.000006560333,0.000029066738,0.000012509069,0.000042257867,0.9978034,0.00010765483,0.0001497036,0.0015761942],"study_design_scores_gemma":[0.0000407401,0.00036958652,0.0066652205,0.000005405126,0.000037665784,0.00018358718,0.000062024854,0.00089794886,0.9800577,0.000070534166,0.011602466,0.000007195541],"about_ca_topic_score_codex":0.0021545189,"about_ca_topic_score_gemma":0.00347622,"teacher_disagreement_score":0.0021545189,"about_ca_system_score_codex":0.00030787484,"about_ca_system_score_gemma":0.00022282539,"threshold_uncertainty_score":0.0061104298},"labels":[],"label_agreement":null},{"id":"W2783240359","doi":"10.1007/s12672-017-0319-0","title":"The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer","year":2018,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Institute of Cancer Research; Canadian Institutes of Health Research","keywords":"Ovarian cancer; Glucocorticoid; Medicine; Adjuvant; Tolerability; Glucocorticoid receptor; Chemotherapy; Oncology; Ex vivo; Pharmacology; In vivo; Cancer; Internal medicine; Cancer research; Biology; Adverse effect","score_opus":0.05219477939617357,"score_gpt":0.3815857450098549,"score_spread":0.32939096561368136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783240359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028581704,0.9993537,0.00001767844,0.00027021274,0.0001100344,0.0000010337386,0.0000059040267,0.0000010852783,0.00021173248],"genre_scores_gemma":[0.00039288352,0.9989171,0.000052433796,0.0003194687,0.00018732765,0.0000016885128,0.000009086308,4.400575e-7,0.00011960852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996871,0.00008093534,0.00007437137,0.00004031511,0.00009493701,0.00002238874],"domain_scores_gemma":[0.99913305,0.0005926753,0.00012027249,0.000015245007,0.00010517389,0.000033548946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079548964,0.00046010764,0.0014985879,0.001799304,0.00027069252,0.001260739,0.0007900207,0.0012442442,0.003365306],"category_scores_gemma":[0.0019796262,0.00026065845,0.0006102828,0.0018386468,0.0005649296,0.0015647149,0.0007422631,0.0021074144,0.0005860399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012289632,0.000036213038,0.0002449845,0.04073178,0.00019663142,0.00018211188,0.00009086315,0.00021947495,0.00044867265,0.0037001786,0.029512372,0.9245139],"study_design_scores_gemma":[0.000057600362,0.00009310623,0.0011061723,0.026977183,0.0005252276,0.0013211854,0.00014164425,0.00009733303,0.00014742937,0.0027652434,0.96673924,0.000028674209],"about_ca_topic_score_codex":0.0019421375,"about_ca_topic_score_gemma":0.0050655976,"teacher_disagreement_score":0.003365306,"about_ca_system_score_codex":0.0006351564,"about_ca_system_score_gemma":0.0015918313,"threshold_uncertainty_score":0.011258066},"labels":[],"label_agreement":null},{"id":"W2809569991","doi":"10.1007/s12672-018-0336-7","title":"Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Lung cancer; Medicine; Androgen receptor; Internal medicine; Oncology; Hazard ratio; Adenocarcinoma; Estrogen receptor; Cancer; Prostate cancer; Proportional hazards model; Breast cancer; Confidence interval","score_opus":0.012110471826498506,"score_gpt":0.3119544523035704,"score_spread":0.2998439804770719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809569991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464214,0.0035311647,0.000042797623,0.00015387328,0.000024499173,0.0000026229525,0.0003315609,0.0000055863225,0.0012657979],"genre_scores_gemma":[0.9989416,0.0003959076,0.000012879363,0.000026435482,0.000020347923,0.0000012305118,0.00020428353,0.0000012342774,0.00039612348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982613,0.000033430366,0.000014497127,0.000024387418,0.000033923734,0.00006755058],"domain_scores_gemma":[0.9993297,0.00015512467,0.00026322925,0.00002826604,0.00007002727,0.0001536614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027496828,0.00013834468,0.00022221985,0.0003938445,0.00021632778,0.00063616055,0.00023829371,0.000387118,0.0019100823],"category_scores_gemma":[0.0013048446,0.00014226137,0.0004042818,0.00058761216,0.0002818682,0.0004588733,0.0002390631,0.00046832833,0.00023935412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010339244,0.00006028881,0.9897267,0.00003510718,0.00015742981,0.00017126728,0.00006267693,0.00016986058,0.00091529154,0.000081909544,0.00033928308,0.0072462065],"study_design_scores_gemma":[0.000011118711,0.00011840261,0.9983651,0.000008836385,0.00009788858,0.00024251745,0.00017977854,0.00019449077,0.00014821769,0.00012281879,0.0005053345,0.000005429235],"about_ca_topic_score_codex":0.0064145676,"about_ca_topic_score_gemma":0.012497399,"teacher_disagreement_score":0.0064145676,"about_ca_system_score_codex":0.00048958824,"about_ca_system_score_gemma":0.00029330768,"threshold_uncertainty_score":0.01275444},"labels":[],"label_agreement":null},{"id":"W2904923544","doi":"10.1007/s12672-018-0353-6","title":"A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy","year":2018,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McGill University; Montreal Neurological Institute and Hospital; Jewish General Hospital","funders":"Prostate Cancer Canada; Jewish General Hospital; Movember Foundation","keywords":"Bivalent (engine); Prostate cancer; Androgen receptor; Prostate; Oncology; Computational biology; Medicine; Internal medicine; Biology; Cancer; Chemistry","score_opus":0.04501632806562778,"score_gpt":0.349986072406982,"score_spread":0.3049697443413542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904923544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7346205,0.07477493,0.05376132,0.003476759,0.0018067188,0.0007037222,0.0029512993,0.0016512069,0.12625352],"genre_scores_gemma":[0.91318077,0.021280011,0.00982674,0.0016458184,0.00013455734,0.00015964046,0.0012401016,0.00009605719,0.052436277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999478,0.000008580401,0.0000018113602,0.000012079737,0.000013785103,0.000015940235],"domain_scores_gemma":[0.9999858,0.0000017585862,0.0000024892975,0.0000015365775,0.0000025938862,0.0000057968437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001228565,0.00034430443,0.00026672773,0.00022108307,0.00024203383,0.00033774186,0.00041432836,0.00030014498,0.0069001745],"category_scores_gemma":[0.000056163375,0.00012090071,0.000153353,0.00020210072,0.00014779548,0.0002394322,0.00030048742,0.00057139626,0.0014526388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007314325,0.0002322078,0.000256375,0.00040014667,0.000051770385,0.0001960115,0.000042032225,0.0012765165,0.9015675,0.004576407,0.00675948,0.08390997],"study_design_scores_gemma":[0.00036769174,0.003881296,0.0026406255,0.00008077671,0.00017418142,0.0016576401,0.000067782305,0.0035320483,0.7431848,0.0010503783,0.24329966,0.00006309095],"about_ca_topic_score_codex":0.00084899476,"about_ca_topic_score_gemma":0.0016212419,"teacher_disagreement_score":0.0069001745,"about_ca_system_score_codex":0.0003475507,"about_ca_system_score_gemma":0.00024409221,"threshold_uncertainty_score":0.02308333},"labels":[],"label_agreement":null},{"id":"W3016993085","doi":"10.1007/s12672-020-00385-3","title":"Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies","year":2020,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Adrenocortical carcinoma; Clinical trial; Capecitabine; Mitotane; Oncology; Internal medicine; Systemic therapy; Intensive care medicine; Malignancy; Cancer","score_opus":0.03410025276196027,"score_gpt":0.32795962104639287,"score_spread":0.2938593682844326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016993085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012297196,0.99938905,0.000030179634,0.00011429641,0.000073351934,0.0000055065234,0.00003258028,0.0000025044326,0.00022965204],"genre_scores_gemma":[0.00071762985,0.9989122,0.00007911017,0.00011852999,0.000076737364,0.0000070286223,0.00003650324,7.037036e-7,0.000051568873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993699,0.00010458453,0.00025733962,0.00009113608,0.00014314259,0.000033851196],"domain_scores_gemma":[0.9977041,0.0015808529,0.00041467178,0.000032374584,0.00021420598,0.000053768577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008902475,0.0008036244,0.0022421551,0.0046673263,0.00039268474,0.001324097,0.0010444048,0.0011988389,0.0031402346],"category_scores_gemma":[0.0023894156,0.0003156526,0.0017201409,0.0056101265,0.00043957366,0.0012761579,0.0006265142,0.00097463786,0.0004811007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002011448,0.000073060844,0.00072991307,0.34240568,0.0007313777,0.00066767004,0.00020950126,0.000452774,0.00083767745,0.0011434908,0.026564538,0.6259832],"study_design_scores_gemma":[0.00010386547,0.0004334415,0.0071596643,0.22291242,0.0068708686,0.010597648,0.00038489458,0.00028550054,0.0005938455,0.0016990843,0.74888456,0.00007419434],"about_ca_topic_score_codex":0.0022638203,"about_ca_topic_score_gemma":0.0034727661,"teacher_disagreement_score":0.0046673263,"about_ca_system_score_codex":0.00084695744,"about_ca_system_score_gemma":0.0022600912,"threshold_uncertainty_score":0.01050514},"labels":[],"label_agreement":null}]}